Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Nicolas Riteau, Jean-François Bernaudin. In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis. Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020

Member's Comments

No comment yet.

Related content which might interest you: The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation Source: Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019 Year: 2020 Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Late Breaking Abstract - 17-oxo-DHA inhibits the NLRP3 inflammasome downstream of mitochondrial ROS and ERK pathway Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017 The activation of NLRP3 inflammasome pathway in COPD is limited in local airways Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Insulin-dependent PI3-Kinase/Akt and ERK signaling pathways inhibit TLR3-mediated HBEC apoptosis Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 JAK–STAT pathway activation in COPD Source: Eur Respir J 2015; 46: 843-845 Year: 2015 Endothelin-1 activates pro-inflammatory signalling pathway via destinct p38MAPK isoforms resulting in downregulation of nuclear p27kip1 Source: Annual Congress 2009 - Airway cell biology Year: 2009 Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Stimulation of NOD1 induces RIP2, TAK1 and p38 MAPK dependent pro-inflammatory signalling in human lung microvascular endothelial cells Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011 Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Cigarette smoke extract inhibits the NLRP3 inflammasome in human macrophages and impairs cell metabolism via NLRP3-independent activation of Caspase-1 Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Activation of WNT co-receptor LRP5  is required for WNT and TGF-ß1 induced fibroblast activation Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 The Hippo pathway effectors TAZ and YAP are sequentially required in lung development. Source: International Congress 2019 – Molecular and experimental paediatric lung disease Year: 2019 Caspase-1 pathway in COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Activation of IL-32 pathway in COPD Source: Annual Congress 2008 - Cell biology of asthma and COPD Year: 2008 Hedgehog pathway activation is altered in COPD patients Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Wnt and TGF-beta signaling in lung development Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 GATA-3 phosphorylation by p38 MAP kinase plays a critical role in regulating Th2 cytokine gene expression Source: Eur Respir J 2003; 22: Suppl. 45, 386s Year: 2003